Palogic Value Management raised its activist position in Health Catalyst to 7.1%, representing 5,374,949 common shares. For investors, the key distinction is the reported 13D activist intent, which identifies the position as activist rather than passive and places the fund’s increased ownership at the center of the disclosure.

Key Highlights

  • Palogic Value Fund bought 174,617 Health Catalyst shares on 8/6/2026 at $1.76 per share.
  • The reported stake includes 5,366,087 shares held by Palogic Value Fund and 8,862 shares in managed accounts.
  • The 7.1% ownership calculation uses 75,256,381 Health Catalyst shares outstanding as of July 31, 2026.

The ownership figure is based on 75,256,381 Health Catalyst (NASDAQ: HCAT) shares outstanding as of July 31, 2026.

Palogic Holds 7.1% Stake

Palogic Value Fund, LP accounts for 5,366,087 shares of the position. Separately managed accounts add 8,862 shares, bringing the reported holding to 5,374,949 common shares. The stock is common stock with a Par Value of $0.001 per share. Palogic Value Fund purchased 174,617 shares on 8/6/2026 at $1.76 per share. It bought another 150,834 shares on 8/11/2026 at $1.70 per share and 11,332 shares on 8/17/2026 at $1.70 per share. Purchases continued with 1,003 shares on 8/18/2026 at $1.70 per share, followed by 1,000 shares on 8/19/2026 at $1.69 per share. The fund acquired 86,971 shares on 8/20/2026 at $1.66 per share and 19,260 shares on 8/21/2026 at $1.60 per share. Palogic Value Management also bought 716 shares on 9/1/2026 at $1.66 per share through managed accounts. The listed prices exclude commissions.

September Letter Addressed Board

A September 4 letter from Palogic Value Management to Health Catalyst’s board praised the completed VitalWare sale. The letter said the transaction had strengthened Health Catalyst’s financial position and moved the Business from a net-debt posture to a net-cash balance sheet. The letter also commended Health Catalyst employees and executive leadership.